CV Therapeutics, Inc. (NASDAQ:CVTX.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.

Featured Broker Partners


Advertisement